Gabapentin is widely prescribed for herniated disc pain, but the clinical evidence supporting its effectiveness for this condition is weak. In a randomized controlled trial comparing gabapentin to placebo for chronic low back pain with a radiating component (the type of pain a herniated disc typically causes), both groups saw about a 30% reduction in pain intensity, with no significant difference between the drug and the placebo. Gabapentin is not FDA-approved for herniated disc pain or radiculopathy. It is approved only for nerve pain following shingles and as an add-on treatment for certain seizures, meaning any use for disc-related pain is off-label.
What the Clinical Evidence Shows
The most relevant trial for people with herniated disc pain specifically looked at patients with chronic low back pain, including a subgroup with radiating leg pain, which is the hallmark symptom of a herniated disc pressing on a nerve. Pain intensity dropped about 30% from baseline in both the gabapentin group and the placebo group. The difference between groups was not statistically significant.
Among patients who completed the study, 26% on gabapentin achieved at least a 50% reduction in pain, compared to 29% on placebo. Physician ratings of improvement were nearly identical: about 37% of gabapentin patients were rated as having at least minimal improvement versus 33% on placebo. Critically, when researchers isolated the subgroup with radiating pain (the closest proxy for lumbar radiculopathy from a herniated disc), pain reduction was similar between gabapentin and placebo both within and between treatment groups.
This doesn’t mean gabapentin never helps anyone with disc pain. Some people do report meaningful relief, and the placebo-controlled setting of a clinical trial doesn’t capture every real-world scenario. But the best available evidence suggests that, on average, gabapentin does not outperform a sugar pill for this specific type of pain.
Why Doctors Prescribe It Anyway
Gabapentin works by binding to a specific part of calcium channels on nerve cells in the spinal cord, which reduces the release of chemical signals that transmit pain. It also appears to dampen overexcited nerve activity through several other pathways, including influencing how the brain’s pain-processing systems amplify or quiet incoming signals. This mechanism makes it effective for certain types of nerve pain, particularly the burning, shooting pain that follows shingles.
Herniated disc pain can involve nerve compression, which is why clinicians sometimes reach for gabapentin. The logic is reasonable: if a bulging disc irritates a nerve root, a drug that calms nerve signaling might help. In practice, though, herniated disc pain is often a mix of inflammation, mechanical compression, and muscle tension, not purely the type of nerve misfiring that gabapentin targets best. Clinical practice guidelines for radiculopathy are inconsistent on this point. A systematic review of multiple guidelines found very little agreement on which medications to recommend, and every drug class, including anticonvulsants like gabapentin, had at least one guideline recommending against its use.
Common Side Effects
Even if the pain relief is uncertain, the side effects are well documented. The most frequent issues are drowsiness, dizziness, and fatigue. Many people also experience coordination problems, blurred vision, or swelling in the hands and feet. These effects tend to be more pronounced during the first few weeks as the dose is gradually increased.
The typical starting approach involves beginning at a low dose and increasing over the first week or so to reach a therapeutic level. Most people are told to give it several weeks at a stable dose before judging whether it’s working, since the drug’s effects on nerve signaling take time to build. If you don’t notice meaningful improvement after a few weeks at a full dose, the medication is generally tapered down rather than stopped abruptly, as sudden discontinuation can cause withdrawal symptoms including anxiety, insomnia, and nausea.
Serious Safety Concerns
The FDA has issued a specific warning about combining gabapentin with opioids or other sedating medications. This combination can cause serious breathing problems, particularly in older adults and people with lung conditions like COPD. Since many people with severe disc pain are also taking opioid painkillers, this interaction is especially relevant. Anti-anxiety medications, sedating antidepressants, and even antihistamines can compound this risk. If you’re taking any of these alongside gabapentin, the breathing risk increases with each additional sedating substance.
What Tends to Work Better
For most herniated discs, the good news is that the body often resolves the problem on its own. The majority of people with a symptomatic herniated disc see significant improvement within six to twelve weeks as inflammation subsides and the disc material shrinks or shifts away from the nerve. During that window, treatments that address inflammation directly, such as NSAIDs, tend to have more consistent evidence behind them for managing pain.
Physical therapy focused on core stabilization, nerve gliding exercises, and gradual return to movement has a strong track record for both pain relief and preventing recurrence. Epidural steroid injections can provide temporary relief for people with significant leg pain who aren’t responding to conservative measures. Surgery is typically reserved for cases where pain persists beyond several months, weakness develops in the leg or foot, or bowel and bladder function is affected.
If you’re currently taking gabapentin for herniated disc pain and it seems to be helping, that experience is valid, even if clinical trials show group averages that favor placebo. Pain is individual, and some component of your pain may respond to the drug’s mechanism. But if you’ve been on it for weeks without noticeable improvement, the evidence suggests that continuing to increase the dose is unlikely to change the outcome, and the side effects become harder to justify.